The PaLS is used to generate a patient-level t-score that reflects patient-reported satisfaction with how well his/her/their facility is doing in discussing life goals with the patient as part of the treatment planning process.
-
-
1.5 Measure Type1.20 Testing Data Sources
-
1.14 Numerator
The numerator is the number of eligible patients from the denominator that completed at least one scorable item of the PaLS (i.e., at least one of the six Likert-type items).
-
1.15 Denominator
All prevalent adult chronic dialysis patients (≥18 y/o) treated by the facility (both In-Center and Home Dialysis) for greater than 90 days during the reporting period, who read and understand English.
-
Exclusions
Exclusions are implicit based on eligibility criteria to complete the survey. These include age less than 18; patient has a kidney transplant; patient with recovered renal function, or lost to follow up; and unable to read and/or understand English (whether self-assessed or self- reported). In our testing we also excluded duplicate patient surveys.
-
OLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityPrimary Care and Chronic Illness Spring 2023
-
Steward Organization Email
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-
Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Spring 2023 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Spring 2023 “Intent to Submit.” Battelle took over the E&M work for the Spring 2023 cycle when developers and/or stewards submitted their full measure information, which for CBE #3742, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2023-06/3742_-_patient_life_goals_survey.zip
To close out this E&M cycle, Battelle published the Spring 2023 measures for pre-evaluation public commenting, convened the E&M standing committees for their measure evaluation meetings, launched the Spring 2023 post-comment period, convened the E&M committees for the post-comment meeting, convened the CSAC to render a final endorsement decision, and executed the appeals period.